This inventor holds 1 USPTO granted patent. Top assignee: Centro De Inmunologia Molecular. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: Amparo E Abraham: Innovator in Immunotherapy
Introduction
Amparo E Abraham is a notable inventor based in Habana, Cuba. He has made significant contributions to the field of immunotherapy, particularly in the treatment of malignancies. His innovative work focuses on targeting gangliosides, which are crucial in the development of effective cancer treatments.
Latest Patents
Amparo E Abraham holds 1 patent for his invention titled "Anti ganglioside monoclonal antibodies." This patent relates to immunotherapy strategies aimed at treating malignancies by targeting gangliosides. Gangliosides are glycosphingolipids found on both normal and malignant cells, with a higher abundance and distinct organization on cancerous cells. The invention provides specific antibodies that recognize these gangliosides, which have recurrent idiotypes and serve as valuable immunoregulators. Additionally, the invention includes anti-idiotypic antibodies against anti-ganglioside antibodies, which can be utilized in vaccination strategies.
Career Highlights
Amparo E Abraham is affiliated with the Centro de Inmunología Molecular, where he continues to advance research in immunotherapy. His work has the potential to significantly impact cancer treatment and improve patient outcomes.
Collaborations
Amparo collaborates with esteemed colleagues, including Ana Maria Lopez and Angel Mauro Fernandez, who contribute to the research and development of innovative therapeutic strategies.
Conclusion
Amparo E Abraham's contributions to immunotherapy exemplify the importance of innovation in the fight against cancer. His work on anti-ganglioside monoclonal antibodies represents a promising advancement in medical science.